Interleukin-4 (IL-4) is a cytokine that induces both proliferation and differentiation and suppresses apoptosis of B cells. Although IL-4 has been shown to activate the phosphatidylinositol 3′ (PI3)-kinase pathway, the role of PI3 kinase in the IL-4 receptor (IL-4R) signaling remains unclear. In this study, we demonstrated that c-Cbl proto-oncogene product is inducibly phosphorylated on tyrosine residues and is associated with the p85 subunit of PI3-kinase by IL-4 stimulation. Overexpression of c-Cbl enhances the PI3-kinase activity and, at the same time, mitogenic activity and survival of cells in the presence of IL-4. However, these effects of c-Cbl were abolished by wortmannin, a specific inhibitor for the PI3 kinase pathway, or by a point mutation at tyrosine 731 of c-Cbl, which is a major binding site for p85. These results indicate that c-Cbl plays a role in linking IL-4R with the PI3 kinase pathway and thus enhancing the mitogenic and survival signals.

INTERLEUKIN-4 (IL-4) is a cytokine that possesses various biological activities. First of all, IL-4 induces proliferation and differentiation of B cells.1 It induces expression of class II major histocompatibility complex molecules on resting B cells and enhances both secretion and cell surface expression of IgE and IgG1. Furthermore, IL-4 upregulates the expression of CD23, the low-affinity Fc receptor for IgE.2 IL-4 is also shown to act not only on B cells, but also on T cells, mast cells, macrophages, and even nonhematopoietic cells.3 The activation of intracellular signaling by IL-4 depends on ligand binding to the IL-4 receptor (IL-4R) complex, composed of IL-4Rα subunit and γc subunit. IL-4Rα subunit is a 140-kD protein, which is sufficient to permit high affinity binding of the IL-4 ligand.4,5 On the other hand, γc subunit is a common component of receptors for IL-2, IL-7, IL-9, and IL-15.6-9Mutations in the γc subunit have been shown to result in X-linked severe combined immunodeficiency (X-SCID).10 The binding of IL-4 to IL-4R induces activation of JAK1 and JAK3 tyrosine kinases, leading to phosphorylation of STAT6.11-14 Another signaling pathway activated by IL-4 is the phosphatidylinositol 3′ (PI3)-kinase pathway. IL-4 induces tyrosine phosphorylation of IRS-1 and/or IRS-2/4PS and their association with the p85 subunit of the PI3 kinase, resulting in activation of the PI3 kinase pathway.15-17 However, the role of the PI3-kinase pathway in the IL-4R signaling pathway remains unclear.

We report in this study that c-Cbl proto-oncogene product is a substrate for the IL-4–induced intracellular signaling. The c-Cbl proto-oncogene was originally identified as a cellular homologue of v-Cbl oncogene, which was cloned from the Cas NS-1 murine leukemia virus.18 The c-Cbl gene product is a 120-kD protein, which contains an NH2-terminal domain with a nuclear localization signal, followed by a RING finger motif.19 The COOH-terminal half of the protein contains a proline-rich domain, which has been shown to function as a ligand for the SH3 domains of several signaling molecules.20-26 Although many growth factors induce tyrosine phosphorylation of c-Cbl,24,25,27-30 the role of this molecule is not well-understood. As far as we know, phosphorylation of c-Cbl is closely related to activation of the Ras signaling pathway. Recent studies have demonstrated that Sli-1, Caenorhabditis elegans(C elegans) homologue of c-Cbl, is a negative regulator of the let-60–mediated signaling pathway, a C eleganscounterpart of the Ras pathway.31,32 However, it has been demonstrated that IL-4 cannot activate the Ras pathway, at least in hematopoietic tissues.33 Therefore, our data showing that IL-4 phosphorylates c-Cbl is somewhat surprising. Thus, we were very interested in the role of phosphorylation of c-Cbl in IL-4R signaling. In the present study, we analyzed the role of c-Cbl in the IL-4R signaling pathway by using various mutants of c-Cbl and obtained data that it enhances the PI3-kinase activity, which is responsible for transmitting mitogenic and antiapoptotic signals in the IL-4R signaling pathway.

Cells and antibodies.

Ba/F3 cells were cultured in RPMI 1640 containing 10% fetal calf serum (FCS) and 0.25 ng/mL of murine interleukin-3 (mIL-3). Anti–c-Cbl antibody, antiphosphotyrosine antibody 4G10, anti-α subunit of IL-4R and antiinfluenza hemagglutinin (HA) epitope tag antibody 12CA5 were purchased from Santa Cruz Biotechnology Inc (Santa Cruz, CA), Upstate Biotechnology Inc (Lake Placid, NY), Genzyme Inc (Cambridge, MA), and Bohehringer Mannheim Inc (Mannheim, Germany), respectively. Anti-p85 antibody was a gift from Y. Fukui (University of Tokyo, Tokyo, Japan).

Construction of c-Cbl mutant cDNAs and transfection.

The human c-cbl cDNA epitope-tagged with a nine amino acid HA peptide (YPYDVPDYA) from the human influenza virus was a kind gift from W.Y. Langdon (University of Western Australia, Nedlands, Australia). The construction of deletion mutants of c-Cbl, ΔRING-Cbl, and ΔPD-Cbl were described previously.34 The tyrosine 731-phenylalanine mutation of c-Cbl was generated by site-directed mutagenesis with the Chameleon Site-Directed mutagenesis kit (Stratagene, La Jolla, CA) according to the manufacturer's instruction. Retrovirus vector was used to transfect cDNAs of c-Cbl and its mutants into Ba/F3 cells as described previously.35 

Immunoprecipitation and immunoblotting.

Before stimulation, cells were starved in RPMI 1640 containing 0.5% FCS for 12 hours. Cells were then stimulated with 10 ng/mL of mIL-4 (PEPRO TECH EC LTD, London, UK) for 5 minutes at 37°C, washed twice with ice-cold phosphate-buffered saline (PBS), and lysed in Triton lysis buffer (0.5% (vol/vol) Triton X-100, 50 mmol/L Tris-HCl pH 7.4, 2 mmol/L phenylmethylsulfonyl fluoride (PMSF), 10 U/mL aprotinin, 1 mmol/L sodium orthovanadate, 1 mmol/L EDTA). Cell lysates were collected and subjected to immunoprecipitation and immunoblotting as described previously.36 The immunoblots were developed with the ProtoBlot system (Promega, Madison, WI) or the ECL system (Amersham, Arlington Heights, IL).

Measurement of PI3-kinase activity.

The kinase activity of PI3-kinase was measured as described previously.37 Briefly, lysates from cells were immunoprecipitated with indicated antibodies. The immunoprecipitates were washed four times in PI3 kinase buffer (20 mmol/L, Tris-HCl pH 7.5, 100 mmol/L NaCl, 0.5 mmol/L EGTA). Then crude brain phosphoinositides (Sigma, St Louis, MO, P-6023) were added to the immunoprecipitates at a final concentration of 0.2 mg/mL. Adenosine triphosphate (ATP), [γ- 32P] ATP and MgCl2 were added and incubated for 20 minutes at room temperature. The lipids were extracted into a chloroform/methanol mixture (1:1, vol/vol). The lipids-containing organic phase was resolved on thin layer chromatography (TLC) plates (Silica Gel 60, Merck, Darmstadt, Germany), developed in chloroform/methanol/ammonia solution (28%)/water (215:190:25:35 mixture) and visualized by autoradiography.

The [3H]thymidine incorporation assay.

Cells were deprived of mIL-3 for 24 hours. Then 1 ng/mL of mIL-4 was added to the medium and incubated for 12 hours. The cells were then labeled with 1 mCi of [3H]thymidine for 3 hours after growth factor stimulation. The amount of nucleotide incorporated into DNA was quantitated by scintillation counting. Each experiment was repeated at least three times and a growth rate was expressed as a ratio over the basal value at no mIL-4 stimulation.

Analysis of chromosomal DNA fragmentation.

To extract the fragmented DNA observed during apoptotic death, 5 × 106 cells were collected and lysed with 400 μL of lysis buffer (10 mmol/L Tris-HCl, pH 7.5, 10 mmol/L EDTA, 0.2 % Triton X-100). The lysate was kept on ice for 10 minutes and centrifuged at 15,000 rpm for 10 minutes. The supernatant was subjected to extraction with phenol/chloroform/isoamylalcohol (25:24:1) followed by ethanol precipitation. The precipitate was dissolved in 20 μL of Tris-EDTA (TE) and incubated for 1 hour with RNase A (2 μg/mL ) at 37°C. DNA fragments were separated by 2% agarose gel electrophoresis and visualized by ethidium bromide staining.

IL-4 induces tyrosine phosphorylation of c-Cbl proto-oncogene product in Ba/F3 cells.

We examined whether c-Cbl is involved in the IL-4R signaling pathway. First, we tested whether stimulation with IL-4 results in phosphorylation of c-Cbl. We confirmed that Ba/F3 cells, a mIL-3–dependent pro-B cell line, express endogenous IL-4R by methionine labeling of cells followed by immunoprecipitation with anti–IL-4R antibody. Because 32D cells are known to express endogenous IL-4R, we used them as a positive control (Fig1A). We then stimulated Ba/F3 cells with mIL-4, lysed, and immunoprecipitated with anti–c-Cbl antibody. The immunoprecipitates were subjected to the antiphosphotyrosine immunoblotting. In this experiment, we found that c-Cbl was inducibly phosphorylated on tyrosine residues by IL-4 stimulation (Fig 1B). This result indicates that c-Cbl is one of the target molecules in the IL-4R signaling pathway.

Fig. 1.

IL-4 phosphorylates c-Cbl on tyrosine residues. (A) Ba/F3 cells express endogenous IL-4R. Methionine-labeled Ba/F3 and 32D cells were lysed, immunoprecipitated with anti-α subunit of IL-4R. The immunoprecipitates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by autoradiography. An arrow indicates the 140-kD α subunit of IL-4R. (B) Tyrosine phosphorylation of c-Cbl by IL-4. Ba/F3 cells were serum-starved for 10 hours and stimulated with murine IL-4 (10 ng/mL) for 5 minutes at 37°C, lysed, and immunoprecipitated with anti–c-Cbl antibody. The immunoprecipitates were subjected to immunoblotting with antiphosphotyrosine antibody, 4G10 (upper panel) or anti–c-Cbl antibody (lower panel). An arrow indicates c-Cbl.

Fig. 1.

IL-4 phosphorylates c-Cbl on tyrosine residues. (A) Ba/F3 cells express endogenous IL-4R. Methionine-labeled Ba/F3 and 32D cells were lysed, immunoprecipitated with anti-α subunit of IL-4R. The immunoprecipitates were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by autoradiography. An arrow indicates the 140-kD α subunit of IL-4R. (B) Tyrosine phosphorylation of c-Cbl by IL-4. Ba/F3 cells were serum-starved for 10 hours and stimulated with murine IL-4 (10 ng/mL) for 5 minutes at 37°C, lysed, and immunoprecipitated with anti–c-Cbl antibody. The immunoprecipitates were subjected to immunoblotting with antiphosphotyrosine antibody, 4G10 (upper panel) or anti–c-Cbl antibody (lower panel). An arrow indicates c-Cbl.

Close modal
Overexpression of c-Cbl enhances the survival effects and the mitogenic signal of IL-4 in Ba/F3 cells, which are abolished by wortmannin.

To examine the roles of c-Cbl in the signaling pathway through IL-4R, we introduced cDNA of c-Cbl into Ba/F3 cells by the retroviral vector and established a stable line, HCbl cells, which overexpress c-Cbl. We confirmed by the anti–c-Cbl immunoblot and, as an internal control, the anti-p85 immunoblot that HCbl cells express c-Cbl 10 times more than parental Ba/F3 cells (Fig 2A). IL-4 is known to generate antiapoptotic and growth signals in IL-4R expressing cell lines38-40 and, as expected, the survival of Ba/F3 cells was prolonged in the presence of IL-4, even if IL-3 was depleted (Fig 2B). However, when HCbl cells were cultured in the presence of IL-4, transient proliferation and survival of cells was significantly enhanced when compared with those of mock cells. Interestingly, both HCbl and mock cells rapidly fell into apoptotic death in the presence of wortmannin, a specific inhibitor of PI3 kinase (Fig 2B). The low molecular weight DNAs were extracted from HCbl and parental Ba/F3 cells cultured in the presence or absence of wortmannin and electrophoresed in an agarose gel. Notably, the ladder pattern typical for apoptotic death was observed for DNAs extracted from cells cultured in the presence of wortmannin and IL-4 for 48 hours (Fig 2C). We performed the thymidine incorporation assay to assess the mitogenic activities of c-Cbl overexpressing cell lines treated with IL-4. Compared with mock cells, the thymidine incorporation into HCbl cells in the presence of IL-4 was significantly enhanced, but in the presence of wortmannin, that into HCbl cells was reduced to the level without IL-4 (Fig 2D). From these data, we can conclude that survival and mitogenic signals were enhanced by overexpression of c-Cbl and that activation of the PI3 kinase pathway is required for generation of these signals.

Fig. 2.

The effects of c-Cbl in IL-4R signaling. (A) Establishment of HCbl cells that overexpress c-Cbl. Lysates from HCbl and mock cells were subjected to the immunoblotting with anti–c-Cbl antibody (upper panel) and anti-p85 antibody (lower panel). Arrows indicate c-Cbl and p85. We think that bands located below p85 are nonspecific bands. (B) Overexpression of c-Cbl enhances transient growth and elongates survival of Ba/F3 cells in the presence of IL-4. HCbl and mock cells were cultured in RPMI containing 5% FCS and IL-4 (1 ng/mL) in the presence (+WT, 50 nmol/L) or absence of wortmannin. (C) Survival effects of IL-4 enhanced by c-Cbl is sensitive to wortmannin. Low molecular weight DNA extracts from HCbl and mock cells cultured with or without IL-4 (1 ng/mL) plus wortmannin (WT, 50 nmol/L) for 48 hours were electrophoresed on an agarose gel (2%). (D) HCbl and mock cells were deprived of IL-3 for 24 hours. IL-4 (1 ng/mL) and wortmannin (WT, 50 nmol/L) were then added to the medium, incubated for 12 hours, and subjected to the [3H]thymidine incorporation assay. The growth rate was expressed as a ratio over the basal values at no IL-4 stimulation.

Fig. 2.

The effects of c-Cbl in IL-4R signaling. (A) Establishment of HCbl cells that overexpress c-Cbl. Lysates from HCbl and mock cells were subjected to the immunoblotting with anti–c-Cbl antibody (upper panel) and anti-p85 antibody (lower panel). Arrows indicate c-Cbl and p85. We think that bands located below p85 are nonspecific bands. (B) Overexpression of c-Cbl enhances transient growth and elongates survival of Ba/F3 cells in the presence of IL-4. HCbl and mock cells were cultured in RPMI containing 5% FCS and IL-4 (1 ng/mL) in the presence (+WT, 50 nmol/L) or absence of wortmannin. (C) Survival effects of IL-4 enhanced by c-Cbl is sensitive to wortmannin. Low molecular weight DNA extracts from HCbl and mock cells cultured with or without IL-4 (1 ng/mL) plus wortmannin (WT, 50 nmol/L) for 48 hours were electrophoresed on an agarose gel (2%). (D) HCbl and mock cells were deprived of IL-3 for 24 hours. IL-4 (1 ng/mL) and wortmannin (WT, 50 nmol/L) were then added to the medium, incubated for 12 hours, and subjected to the [3H]thymidine incorporation assay. The growth rate was expressed as a ratio over the basal values at no IL-4 stimulation.

Close modal
The ΔPD mutant of c-Cbl is not tyrosine-phosphorylated by IL-4, whereas the ΔRING mutant is tyrosine-phosphorylated.

To examine the mechanism of how c-Cbl enhances the survival and mitogenic signals transmitted by IL-4R, we first tested which domain of c-Cbl is phosphorylated on tyrosine residues by IL-4 treatment. We constructed deletion mutants of c-Cbl, ΔRING-Cbl, which lacks amino acids (aa) 193-491 including the RING finger domain and ΔPD-Cbl, which lacks aa 492-877 including the proline-rich domain of c-Cbl (Fig3A) and introduced them into Ba/F3 cells by the retroviral vector and established stable transfectants, ΔRING and ΔPD cells. The cDNAs for wild-type c-Cbl and both deletion constructs were epitope-tagged with an HA peptide and therefore distinguishable from endogenous c-Cbl protein (Fig 3B). We examined if these deletion mutants of c-Cbl were phosphorylated by IL-4 treatment, finding that the ΔPD mutant of c-Cbl was not tyrosine-phosphorylated by IL-4, whereas the ΔRING mutant was tyrosine-phosphorylated (Fig 3B). This result indicates that it is within aa 497-877 of c-Cbl, which is phosphorylated by IL-4 stimulation. Next, HCbl, ΔRING, ΔPD, and mock cells were cultured in the presence of IL-4 and subjected to the thymidine incorporation assay. We found in this experiment that while the levels of thymidine incorporated into HCbl and ΔRING cells treated with IL-4 were approximately the same, that of ΔPD cells was significantly decreased (Fig 4), suggesting that the region within aa 497-877 of c-Cbl is required for generating mitogenic signals.

Fig. 3.

IL-4 phosphorylates the region within aa 492-877 of c-Cbl. (A) Constructs of cDNAs for wild-type and deletion mutants of c-Cbl epitope-tagged with an HA peptide. ▿RING-Cbl lacks aa 193-491 including the RING finger domain and ▿PD-Cbl lacks aa 492-877 including the proline-rich domain of c-Cbl. HA, a nine amino acid HA peptide (YPYDVPDYA) from the human influenza virus. RING, the RING finger motif. LZ, the leucine zipper motif. (B) Expression and tyrosine phosphorylation of deletion mutants of c-Cbl by IL-4 stimulation. The cDNAs encoding deletion mutants, ▿RING-Cbl and ▿PD-Cbl, were introduced into Ba/F3 cells by the retroviral vector, and stable transfectants, ▿RING and ▿PD cells were established. These cells were stimulated with IL-4 (10 ng/mL) for 5 minutes at 37°C, lysed, and immunoprecipitated with anti–c-Cbl antibody. The immunoprecipitates were then subjected to the immunoblotting with antiphosphotyrosine antibody (upper panel) or anti-HA monoclonal antibody, 12CA5 (lower panel).

Fig. 3.

IL-4 phosphorylates the region within aa 492-877 of c-Cbl. (A) Constructs of cDNAs for wild-type and deletion mutants of c-Cbl epitope-tagged with an HA peptide. ▿RING-Cbl lacks aa 193-491 including the RING finger domain and ▿PD-Cbl lacks aa 492-877 including the proline-rich domain of c-Cbl. HA, a nine amino acid HA peptide (YPYDVPDYA) from the human influenza virus. RING, the RING finger motif. LZ, the leucine zipper motif. (B) Expression and tyrosine phosphorylation of deletion mutants of c-Cbl by IL-4 stimulation. The cDNAs encoding deletion mutants, ▿RING-Cbl and ▿PD-Cbl, were introduced into Ba/F3 cells by the retroviral vector, and stable transfectants, ▿RING and ▿PD cells were established. These cells were stimulated with IL-4 (10 ng/mL) for 5 minutes at 37°C, lysed, and immunoprecipitated with anti–c-Cbl antibody. The immunoprecipitates were then subjected to the immunoblotting with antiphosphotyrosine antibody (upper panel) or anti-HA monoclonal antibody, 12CA5 (lower panel).

Close modal
Fig. 4.

The thymidine incorporation assay of deletion mutants of c-Cbl in the presence of IL-4. HCbl, ▿RING and ▿PD cells were subjected to the thymidine incorporation assay. The growth rates were expressed as in Fig 2D. The data for HCbl cells are the same as presented in Fig 2D.

Fig. 4.

The thymidine incorporation assay of deletion mutants of c-Cbl in the presence of IL-4. HCbl, ▿RING and ▿PD cells were subjected to the thymidine incorporation assay. The growth rates were expressed as in Fig 2D. The data for HCbl cells are the same as presented in Fig 2D.

Close modal
Tyrosine 731 of c-Cbl is required for transmission of mitogenic signal in IL-4R signaling.

We hypothesized from the results presented above that the PI-3 kinase pathway is required for transmission of survival mitogenic signals enhanced by c-Cbl. The SH2 domain of p85 subunit of PI3 kinase is known to bind to c-Cbl phosphorylated by T-cell receptor activation,23 but the binding site on c-Cbl has not been identified. There are two potential binding sequences for the SH2 domain of p85 on aa 371-374 and aa 731-734 of c-Cbl, which are known as YXXM motifs.41 42 Because, as indicated above, the region phosphorylated by IL-4R is located within aa 492-877 of c-Cbl, it is most likely that the binding site for the SH2 domain of p85 is tyrosine 731. To confirm this hypothesis, we introduced a tyrosine 731-phenylalanine mutation into the c-Cbl cDNA and established a stable Ba/F3 cell line, YF, which expresses the Y731F mutant of c-Cbl (Fig5A). To confirm that tyrosine 731 of c-Cbl is the major binding site for p85, HCbl and YF cells stimulated with IL-4 were lysed and immunoprecipitated with anti-p85 antibody. The immunoprecipitates were subjected to immunoblotting with anti-HA antibody, which recognizes introduced c-Cbl and its mutants, but not endogenous c-Cbl protein. In this experiment, while p85 could coprecipitate wild-type c-Cbl, it could not coprecipitate the Y731F mutant of c-Cbl (Fig 5B). These data support that the binding site for p85 on c-Cbl is tyrosine 731. We also performed immunoprecipitation with anti-HA followed by immunoblotting with anti-p85 antibody and could observe that p85 was inducibly coimmunoprecipitated with the wild-type c-Cbl, but not with the Y731F mutant of c-Cbl (data not shown).

Fig. 5.

The Y731F mutant of c-Cbl cannot associate with p85 by IL-4 stimulation. (A) The establishment of YF cells, which stably express Y731F mutant of c-Cbl. Lysates from mock, HCbl, and YF cells were immunoprecipitated with anti–c-Cbl antibody and subjected to the immunoblotting with anti-HA antibody, 12CA5. The construct of Y731F mutant of c-Cbl is presented in Fig 3A. An arrow indicates c-Cbl. (B) Y731F c-Cbl mutant cannot associate with p85. Lysates from HCbl and YF stimulated with IL-4 (10 ng/mL) for 5 minutes at 37°C were immunoprecipitated with anti-p85 antibody, followed by the immunoblotting with antiphosphotyrosine antibody (upper panel) or anti-p85 antibody (lower panel). An arrow indicates c-Cbl.

Fig. 5.

The Y731F mutant of c-Cbl cannot associate with p85 by IL-4 stimulation. (A) The establishment of YF cells, which stably express Y731F mutant of c-Cbl. Lysates from mock, HCbl, and YF cells were immunoprecipitated with anti–c-Cbl antibody and subjected to the immunoblotting with anti-HA antibody, 12CA5. The construct of Y731F mutant of c-Cbl is presented in Fig 3A. An arrow indicates c-Cbl. (B) Y731F c-Cbl mutant cannot associate with p85. Lysates from HCbl and YF stimulated with IL-4 (10 ng/mL) for 5 minutes at 37°C were immunoprecipitated with anti-p85 antibody, followed by the immunoblotting with antiphosphotyrosine antibody (upper panel) or anti-p85 antibody (lower panel). An arrow indicates c-Cbl.

Close modal
The PI3 kinase activation by IL-4 treatment was enhanced in HCbl cells, but not in YF-Ba/F3 cells.

First, we confirmed that IL-4 simulation enhances c-Cbl–associated PI3 kinase activity. Ba/F3 cells treated with or without IL-4 were lysed and immunoprecipitated with anti–c-Cbl antibody. The immunoprecipitates were subjected to the PI3 kinases assay. As expected, enhancement of c–Cbl-associated PI3 kinase activity by IL-4 treatment was observed (Fig 6A). This result indicates that c-Cbl can connect IL-4R with the PI3 kinase pathway. If this is the case, overexpression of c-Cbl should enhance the PI-3 kinase activity in Ba/F3 cells by IL-4 treatment and, to the contrary, the Y731F mutant of c-Cbl, which cannot bind to p85, could not. To examine this, HCbl, YF, and mock cells stimulated with IL-4 were lysed and immunoprecipitated with antiphosphotyrosine antibody. The immunoprecipitates were then subjected to the PI3 kinase assay. As expected, PI3 kinase activity in HCbl was significantly enhanced when compared with that of mock cells, while that of YF cells was approximately equal to the level of mock cells (Fig 6B). We next performed the thymidine incorporation assay to assess the mitogenic activities of HCbl and YF cells and found that the Y731F-Cbl mutant could not enhance the DNA synthesis as did the wild-type c-Cbl (Fig6C). If the c–Cbl-PI3 kinase pathway is responsible for enhancing transient growth and survival effects of IL-4 observed in Fig 2, we can expect that growth and survival of YF cells in the presence of IL-4 should not be enhanced as HCbl cells. As expected, growth of YF cells in the presence of IL-4 was similar to that of parental Ba/F3 cells (Fig 6D). All of these results indicate that tyrosine 731 of c-Cbl, which is a binding site for p85, is critical for transmitting mitogenic signal of IL-4R, suggesting that the PI3-kinase pathway plays a role in enhancing DNA synthesis, transient growth, and survival of cells.

Fig. 6.

Tyrosine 731 of c-Cbl is critical for enhancing PI3 kinase activity. (A) IL-4 activates c-Cbl–associated PI3 kinase in Ba/F3 cells. Lysates from Ba/F3 cells stimulated with or without IL-4 were immunoprecipitated with anti–c-Cbl antibody. The immunoprecipitates were subjected to the PI3 kinase assay. (B) The PI3 kinase assay of mock, HCbl, and YF cells stimulated with or without IL-4. Lysates from mock, HCbl and YF cells stimulated with or without IL-4 were immunoprecipitated with antiphosphotyrosine antibody. The immunoprecipitates were then subjected to the PI-3 kinase assay. (C) The thymidine incorporation assay of HCbl and YF cells in the presence or absence of IL-4 (10 ng/mL). The growth rates were expressed as in Fig 2D. The data for HCbl cells are the same as presented in Fig 2D. (D) Growth of HCbl and YF cells in the presence of IL-4. HCbl and mock cells were cultured in RPMI containing 5% FCS and IL-4 (1 ng/mL), but without IL-3. The data for HCbl cells are the same as presented in Fig 2B.

Fig. 6.

Tyrosine 731 of c-Cbl is critical for enhancing PI3 kinase activity. (A) IL-4 activates c-Cbl–associated PI3 kinase in Ba/F3 cells. Lysates from Ba/F3 cells stimulated with or without IL-4 were immunoprecipitated with anti–c-Cbl antibody. The immunoprecipitates were subjected to the PI3 kinase assay. (B) The PI3 kinase assay of mock, HCbl, and YF cells stimulated with or without IL-4. Lysates from mock, HCbl and YF cells stimulated with or without IL-4 were immunoprecipitated with antiphosphotyrosine antibody. The immunoprecipitates were then subjected to the PI-3 kinase assay. (C) The thymidine incorporation assay of HCbl and YF cells in the presence or absence of IL-4 (10 ng/mL). The growth rates were expressed as in Fig 2D. The data for HCbl cells are the same as presented in Fig 2D. (D) Growth of HCbl and YF cells in the presence of IL-4. HCbl and mock cells were cultured in RPMI containing 5% FCS and IL-4 (1 ng/mL), but without IL-3. The data for HCbl cells are the same as presented in Fig 2B.

Close modal

The signaling pathway of IL-4R is summarized in Fig7. In this study, we demonstrated that, like IRS-1 and IRS-2, c-Cbl plays a role in linking IL-4R with the PI3 kinase pathway, which enhances mitogenic and antiapoptotic signals of IL-4R.

Fig. 7.

Schematic representation of the signaling pathway of IL-4R. In this study, we showed that c-Cbl serves as a second pathway linking IL-4R with the PI3 kinase pathway. α, the α subunit of IL-4R; γc, the γ subunit of IL-4R; c-Akt, c-Akt serine/threonine kinase.49 

Fig. 7.

Schematic representation of the signaling pathway of IL-4R. In this study, we showed that c-Cbl serves as a second pathway linking IL-4R with the PI3 kinase pathway. α, the α subunit of IL-4R; γc, the γ subunit of IL-4R; c-Akt, c-Akt serine/threonine kinase.49 

Close modal

In this study, we presented data showing that c-Cbl is a substrate for IL-4R signaling. IL-4 phosphorylates c-Cbl on tyrosine residues and then c-Cbl enhances mitogenic and survival signals evoked by IL-4R. These effects of c-Cbl are considered to be generated by linking IL-4R with the PI3 kinase pathway, because wortmannin, a specific inhibitor for the PI3 kinase pathway, abolished the effects of c-Cbl. It is well-known that IL-4 stimulation of IL-4R–expressing cells phosphorylates IRS-1 and IRS-2 on tyrosine residues, resulting in their association with the p85 subunit of PI3 kinase. Thus, one of the roles of IRS protein in the IL-4R signaling pathway is to link IL-4R with the PI3 kinase pathway. Our data demonstrated in the present study indicate that c-Cbl functions as a second molecule that links IL-4R with the PI3 kinase pathway.

A recent study on c-Cbl demonstrated that the SH3 domain of p85 constitutively binds to the proline rich domain of c-Cbl, but this interaction is weak. On tyrosine-phosphorylation of c-Cbl, the SH2 domain of p85 also binds to c-Cbl, achieving a more tight association.43 There are two YXXM motifs, which are potential binding motifs for the SH2 domain of p85 on human c-Cbl protein, at aa 371-374 and aa 731-734. From the data that IL-4 did not phosphorylate the ΔPD-Cbl mutant, which lacks aa 492-877, we can speculate that the binding site of c-Cbl for the SH2 domain of p85 should be tyrosine 731. Therefore, we constructed tyrosine-731 phenylalanine mutant of c-Cbl. As expected, IL-4–induced association between p85 and c-Cbl was considerably reduced by introducing the Y731F mutation. Moreover, the Y731F mutant of c-Cbl could not enhance PI3 kinase activity.

The next question is what is the role of the PI3 kinase pathway in the IL-4R signaling pathway. Interestingly, Yao et al44reported that the PI3 kinase pathway is responsible for generating survival signals activated by nerve growth factor (NGF) and platelet-derived growth factor (PDGF) in PC12 cells. Moreover, recent studies indicate that c-Akt serine/threonine kinase, which is a direct target of PI-3 kinase, regulates neuronal survival.45-47 Because IL-4 is known to suppress apoptosis of B cells,38-40 it is likely that the PI-3 kinase-c–Akt pathway plays a critical role in enhancing the survival signal through IL-4R. Combined with our data that c-Cbl–overexpressing cells showed enhanced PI-3 kinase activity in the presence of IL-4, it is likely that c-Cbl contributes to the survival effects of IL-4 by connecting with the PI3 kinase-c-Akt pathway (Fig 7). Moreover, transient elevation of DNA synthesis was observed in c-Cbl–overexpressing cells when treated with IL-4, which was abolished in the presence of wortmannin or by generating the Y731F mutation into c-Cbl. These data indicate that the PI3 kinase pathway contributes to the mitogenic signal of IL-4.

We do not know yet the tyrosine kinase, which phosphorylates c-Cbl or which region of IL-4R is required for phosphorylation of c-Cbl. Because IL-4 is known to activate JAK1 and JAK3 tyrosine kinases,11-13 it is possible that c-Cbl is phosphorylated by JAK kinases, but we have not obtained any supporting data. By using various IL-4R mutants, Deutsch et al48 reported that distinct regions of IL-4R differentially regulate apoptosis inhibition and cell growth. They demonstrated that the proline- rich motif (PRM) (P242-K264) and the acidic region (S330-S365) are required for both growth and apoptosis inhibition effects.48 These regions are distinct from the NPXY motif, which is required for IRS protein phosphorylation. Because our data in the present study indicate that c-Cbl enhances both growth and survival signals of IL-4, the PRM or the acidic region on IL-4R might be involved in c-Cbl phosphorylation. Currently, the mechanism of how IL-4R phosphorylates c-Cbl and what differential roles c-Cbl and IRS protein play are under investigation.

The human c-Cbl cDNA was a kind gift of W.Y. Langdon. We thank Y. Fukui for the anti-p85 antibody. We also thank O.N. Witte for the expression vector.

Supported in part by grants-in-aid from the Ministry of Education, Science, and Culture of Japan and from the Ministry of Health and Welfare of Japan, Tokyo, Japan.

Address reprint requests to Hisamaru Hirai, MD, Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. section 1734 solely to indicate this fact.

1
Keegan
A
Nelms
K
Wang
L
Pierce
J
Paul
W
IL-4 receptor: Signaling mechanisms.
Immunol Today
15
1994
423
2
Widmer
MB
Acres
RB
Sassenfeld
HM
Grabstein
KH
Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.
J Exp Med
166
1987
1447
3
Murata
T
Noguchi
PD
Puri
RK
Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.
J Biol Chem
270
1995
30829
4
Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, Friend D, Alpert A, Anderson D, Jackson J, Wignall JM, Smith C, Gallis B, Sims JE, Urdal D, Widmer MB, Cosman D, Park LS: The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335, 1989
5
Harada
N
Castle
BE
Gorman
DM
Itoh
N
Schreurs
J
Barrett
RL
Howard
M
Miyajima
A
Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding.
Proc Natl Acad Sci USA
87
1990
857
6
Takeshita
T
Asao
H
Ohtani
K
Ishii
N
Kumaki
S
Tanaka
N
Munakata
H
Nakamura
M
Sugamura
K
Cloning of the gamma chain of the human IL-2 receptor.
Science
257
1992
379
7
Noguchi
M
Nakamura
Y
Russell
SM
Ziegler
SF
Tsang
M
Cao
X
Leonard
WJ
Interleukin-2 receptor gamma chain: A functional component of the interleukin-7 receptor.
Science
262
1993
1877
8
Giri
JG
Ahdieh
M
Eisenman
J
Shanebeck
K
Grabstein
K
Kumaki
S
Namen
A
Park
LS
Cosman
D
Anderson
D
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.
EMBO J
13
1994
2822
9
Kondo
M
Takeshita
T
Higuchi
M
Nakamura
M
Sudo
T
Nishikawa
S
Sugamura
K
Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes.
Science
263
1994
1453
10
Puck
JM
Deschenes
SM
Porter
JC
Dutra
AS
Brown
CJ
Willard
HF
Henthorn
PS
The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
Hum Mol Genet
2
1993
1099
11
Yin
T
Tsang
ML
Yang
YC
JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes.
J Biol Chem
269
1994
26614
12
Brunn
GJ
Falls
EL
Nilson
AE
Abraham
RT
Protein-tyrosine kinase-dependent activation of STAT transcription factors in interleukin-2- or interleukin-4-stimulated T lymphocytes.
J Biol Chem
270
1995
11628
13
Lai
S
Molden
J
Liu
K
Puck
J
White
M
Goldsmith
M
Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor a subunit.
EMBO J
15
1996
4506
14
Takeda
K
Tanaka
T
Shi
W
Matsumoto
M
Minami
M
Kashiwamura
S
Nakanishi
K
Yoshida
N
Kishimoto
T
Akira
S
Essential role of Stat6 in IL-4 signalling.
Nature
380
1996
627
15
Wang
LM
Keegan
AD
Li
W
Lienhard
GE
Pacini
S
Gutkind
JS
Myers
MJ
Sun
XJ
White
MF
Aaronson
SA
Paul
WE
Pierce
JH
Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells.
Proc Natl Acad Sci USA
90
1993
4032
16
Seldin
DC
Leder
P
Mutational analysis of a critical signaling domain of the human interleukin 4 receptor.
Proc Natl Acad Sci USA
91
1994
2140
17
Sun
XJ
Wang
L-M
Zhang
Y
Yenush
L
Myers Jr
MG
Glasheen
E
Lane
WS
Pierce
JH
White
MF
Role of IRS-2 in insulin and cytokine signaling.
Nature
377
1995
173
18
Langdon WY, Hyland CD, Grumont RJ, Morse Hd: The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein. J Virol 63:5420, 1989
19
Blake TJ, Shapiro M, Morse Hd, Langdon WY: The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653, 1991
20
Donovan
JA
Wange
RL
Langdon
WY
Samelson
LE
The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor.
J Biol Chem
269
1994
22921
21
Rivero
LO
Sameshima
JH
Marcilla
A
Robbins
KC
Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene.
J Biol Chem
269
1994
17363
22
de Jong
R
ten Hoeve
J
Heisterkamp
N
Groffen
J
Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.
J Biol Chem
270
1995
21468
23
Meisner
H
Conway
BR
Hartley
D
Czech
MP
Interactions of Cbl with Grb2 and phosphatidylinositol 3'-kinase in activated Jurkat cells.
Mol Cell Biol
15
1995
3571
24
Odai
H
Sasaki
K
Iwamatsu
A
Hanazono
Y
Tanaka
T
Mitani
K
Yazaki
Y
Hirai
H
The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells.
J Biol Chem
270
1995
10800
25
Odai
H
Sasaki
K
Hanazono
Y
Ueno
H
Tanaka
T
Miyagawa
K
Mitani
K
Yazaki
Y
Hirai
H
c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-src in v-src-transformed fibroblasts.
Jpn J Cancer Res
86
1995
1119
26
Ribon
V
Hubbell
S
Herrera
R
Saltiel
AR
The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner.
Mol Cell Biol
16
1996
45
27
Sasaki
K
Odai
H
Hanazono
Y
Ueno
H
Ogawa
S
Langdon
WY
Tanaka
T
Miyagawa
K
Mitani
K
Yazaki
Y
Hirai
H
TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules.
Biochem Biophys Res Commun
216
1995
338
28
Tanaka
S
Neff
L
Baron
R
Levy
JB
Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways.
J Biol Chem
270
1995
14347
29
Galisteo
ML
Dikic
I
Batzer
AG
Langdon
WY
Schlessinger
J
Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.
J Biol Chem
270
1995
20242
30
Levkowitz
G
Klapper
LN
Tzahar
E
Freywald
A
Sela
M
Yarden
Y
Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins.
Oncogene
12
1996
1117
31
Jongeward
GD
Clandinin
TR
Sternberg
PW
sli-1, a negative regulator of let-23-mediated signaling in C. elegans.
Genetics
139
1995
1553
32
Yoon
CH
Lee
J
Jongeward
GD
Sternberg
PW
Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl.
Science
269
1995
1102
5
33
Welham
MJ
Duronio
V
Schrader
JW
Interleukin-4-dependent proliferation dissociates p44erk-1, p42erk-2, and p21ras activation from cell growth.
J Biol Chem
269
1994
5865
34
Ueno
H
Sasaki
K
Miyagawa
K
Honda
H
Mitani
K
Yazaki
Y
Hirai
H
Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the Ras pathway in EGF receptor signaling.
J Biol Chem
272
1997
8739
35
Ueno
H
Sasaki
K
Kozutsumi
H
Miyagawa
K
Mitani
K
Yazaki
Y
Hirai
H
Growth and survival signals transmitted via two distinct NPXY motifs within leukocyte tyrosine kinase, an insulin receptor-related tyrosine kinase.
J Biol Chem
271
1996
27707
36
Ueno
H
Hirano
N
Kozutsumi
H
Sasaki
K
Tanaka
T
Yazaki
Y
Hirai
H
An epidermal growth factor receptor-leukocyte tyrosine kinase chimeric receptor generates ligand-dependent growth signals through the Ras signaling pathway.
J Biol Chem
270
1995
20135
37
Yamauchi
T
Tobe
K
Tamemoto
H
Ueki
K
Kaburagi
Y
Yamamoto
HR
Takahashi
Y
Yoshizawa
F
Aizawa
S
Akanuma
Y
Sonenberg
N
Yazaki
Y
Kadowaki
T
Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice.
Mol Cell Biol
16
1996
3074
38
Kelso
A
Troutt
AB
Survival of the myeloid progenitor cell line FDC-P1 is prolonged by interferon-gamma or interleukin-4.
Growth Factors
6
1992
233
39
Keegan
AD
Nelms
K
White
M
Wang
LM
Pierce
JH
Paul
WE
An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth.
Cell
76
1994
811
40
Parry
SL
Hasbold
J
Holman
M
Klaus
GG
Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40.
J Immunol
152
1994
2821
41
Songyang
Z
Shoelson
SE
Chaudhuri
M
Gish
G
Pawson
T
Haser
WG
King
F
Roberts
T
Ratnofsky
S
Lechleider
RJ
Neel
BG
Birge
RB
Fajardo
JE
Chou
MM
Hanafusa
H
Schaffhausen
B
Cantley
LC
SH2 domains recognize specific phosphopeptide sequences.
Cell
72
1993
767
42
Songyang
Z
Shoelson
SE
McGlade
J
Olivier
P
Pawson
T
Bustelo
XR
Barbacid
M
Sabe
H
Hanafusa
H
Yi
T
Ren
R
Baltimore
D
Rantnofsky
S
Feldman
RA
Cantley
LC
Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.
Mol Cell Biol
14
1994
2777
43
Sattler
M
Salgia
R
Okuda
K
Uemura
N
Durstin
MA
Pisick
E
Xu
G
Li
JL
Prasad
KV
Griffin
JD
The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Oncogene
12
1996
839
44
Yao
R
Cooper
GM
Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.
Science
267
1995
2003
45
Franke
TF
Yang
SI
Chan
TO
Datta
K
Kazlauskas
A
Morrison
DK
Kaplan
DR
Tsichlis
PN
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.
Cell
81
1995
727
46
Burgering
BM
Coffer
PJ
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.
Nature
376
1995
599
47
Dudek
H
Datta
SR
Franke
TF
Birnbaum
MJ
Yao
R
Cooper
GM
Segal
RA
Kaplan
DR
Greenberg
ME
Regulation of neuronal survival by the serine-threonine protein kinase Akt.
Science
275
1997
661
48
Deutsch
HH
Koettnitz
K
Chung
J
Kalthoff
FS
Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth.
J Immunol
154
1995
3696
49
Bellacosa
A
Testa
JR
Staal
SP
Tsichlis
PN
A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region.
Science
254
1991
274
Sign in via your Institution